MARKER THERAPEUTICS, INC. Subscription and Circulation Revenue (Deprecated 2018-01-31)
MARKER THERAPEUTICS, INC. (MRKR) reported Subscription and Circulation Revenue (Deprecated 2018-01-31) of -$140.00 thousand for the 179-month period ending 2014-06-30, per its 10-Q filed 2014-08-18.
Discontinued › Income Statement › Other Income
us-gaap:SubscriptionRevenue · last filed 2014-08-18
- 2014-06-30: Subscription and Circulation Revenue (Deprecated 2018-01-31) 179 month -$140.00K.
- 2011-04-30: Subscription and Circulation Revenue (Deprecated 2018-01-31) 1 month $90.00K.
| Period end | Subscription and Circulation Revenue (Deprecated 2018-01-31) 1 month | Subscription and Circulation Revenue (Deprecated 2018-01-31) 179 month |
|---|---|---|
| 2014-06-30 | -$140.00K 10-Q · filed 2014-08-18 | |
| 2011-04-30 | $90.00K 10-Q/A · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |